An underground economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.
Experimental Treatment Gaining Popularity Via Social Media
Retatrutide, which is still in clinical trials, is being advertised by online personalities for its supposed fat-burning properties. Viewers are encouraged to message these profiles directly for supplier links, while also obtaining promotional offers.
Active Commerce on Messaging Platforms
Additionally, a flourishing trade exists on messaging services, where groups with thousands of participants share “before and after” images, injection guides and assertions of rapid British shipping. Vendors market the substance there before redirecting buyers to WhatsApp for transactions.
Learning About The Experimental Drug
Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help patients lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.
Medical Professionals Voice Worries
However, doctors and chemists have cautions that the sale of what remains an unlicensed drug in the UK is a cause for concern and could lead to individuals administering products of unknown origin.
Some professionals said the popularity for the experimental drug could be linked to the rising price of approved weight loss treatments such as Mounjaro.
Legal Status and Implementation
Selling retatrutide on social media or messaging apps is prohibited in the UK, as it is an unapproved drug that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.
Several content creators try to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still breach medicines, marketing, and consumer laws, potentially leading to penalties, prosecution or imprisonment.
Service Reaction and Material Removal
Based on TikTok, the platform has removed problematic content and banned related keywords and query recommendations. The organization said it was committed to maintaining the service secure and investing in enhancing compliance measures.
Online Marketplace Operations
Research also discovered communities with up to 9,000 members marketing the experimental drug using Telegram's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly brings up groups with thousands of members, populated with images of slimming results, glowing testimonials and step-by-step instructions for preparing or injecting at residence.
Within moments of entering one community, a vendor shared WhatsApp details, where most purchases occur. The seller provided an guidebook and promised shipping within 48 hours. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one inquired about weight, medical conditions or previous experience.
Item Details and Pricing
Within these groups, messages show dark colored parcels with postal service stickers, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at home with sterile water, or ready-to-use pens usually sold at £160 for 20 milligrams. When asked how long a injector should be used, sellers give contradictory answers ranging from a several days to “depends on your body”.
Platform Oversight and Security Actions
A representative for Telegram stated it regularly monitored harmful material on its platform including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“People are administering materials they cannot confirm. Even if the science behind retatrutide is valid, these online products may not include what they advertise,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor linked the increase in interest to current price rises for authorized slimming drugs such as Mounjaro. “With prices increasing, patients are using social media. But counterfeit treatments are extremely dangerous. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she explained.
Her staff has previously encountered patients harmed by self-injection from unconfirmed sources. “We recognize the frustration, but purchasing from Telegram or communication platforms is gambling with your health,” stated the doctor. “These substances could be impure or improperly measured.”
Manufacturer Statement
A spokesperson from the pharmaceutical company stated retatrutide was in third stage research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they said, adding that any item “falsely representing itself as a company experimental substance not yet authorized … may subject users to possibly serious health risks”.
